Fingerprint
Dive into the research topics of 'Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
Ting Yang, Yifan Dang, Beth Ostaszewski, David Mengel, Verena Steffen, Christina Rabe, Tobias Bittner, Dominic M. Walsh, Dennis J. Selkoe
Research output: Contribution to journal › Article › peer-review
65
Scopus
citations